Medtronic PLC (MDT)

NASDAQHealthcare

$99.81
+$1.2 (+1.2%)

January 21, 2026 at 19:16 UTC

Interactive Chart
MDT
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Medtronic PLC

Name

Medtronic PLC

CEO

Geoffrey Straub Martha

Industry

Healthcare

Year Founded

1949

Employees

95,000

Medtronic plc is a medical technology company that develops devices and therapies used in surgical, cardiac, neurological, and diabetes care. The operating model links research with manufacturing, clinician training, and post-market support so new options move from trials to daily practice with consistent standards. Hospitals adopt systems with credentialing and protocols that fit existing routines, while service teams help keep equipment available and therapies monitored. Guidance materials focus on safe initiation and follow-up rather than marketing language, and supply planning aims for continuity once adoption begins. With operations across many regions, Medtronic’s contribution to the healthcare ecosystem is pragmatic: turn engineering into therapies clinicians can trust and patients can live with over the long term.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 5 Buy, 9 Hold, 7 Sell
Buy5
Hold9
Sell7
Fundamentals & Financials
Revenue (TTM)
$34.7B
Net Income (TTM)
$4.7B
EPS (TTM)
$3.71
ROA (TTM)
5.22%
Current Ratio
2.42
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ4 2025
Revenue$8,961M
Cost of Sales$3,556M
Gross Profit$5,405M
Operating Income$1,685M
Net Income$1,374M
EPS$1.07
Technical Indicators

Medtronic PLC's Technical Indicators Summary

MDT is currently exhibiting a neutral technical profile as the trend strength remains weak with an ADX below 16, indicating limited directional momentum. Momentum indicators like RSI and CCI hover near mid-range levels, suggesting neither strong buying nor selling pressure, while the MACD also signals a hold. The price sits just below several short- and medium-term moving averages, which are trending downward, but remains above the longer-term 200-day averages that continue to offer some support. Volatility, as measured by ATR, is moderate, and volume indicators such as OBV show slight selling pressure. Overall, these mixed signals reflect a market in balance without a clear directional bias. The technical takeaway is that MDT currently maintains a cautious, neutral stance.

Buy
5 signals
Neutral
9 signals
Sell
7 signals
Overall: Neutral43% Neutral signals
IndicatorValue
RSI (14)
44.93
Stochastic %K (14, 3, 3)
48.73
CCI (20)
-10.92
WPR (14)
-74.15
Momentum (10)
0.71
MFI
45.57
MACD Level (12, 26)
-0.22
Bollinger Bands
$95.11 - $100.14
ATR (14)
$1.79 (1.85%)
ADX (14)
15.98
OBV
127,730,300
Simple Moving Averages
$91.74 - $98.49(5 indicators)
Exponential Moving Averages
$93.25 - $97.98(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

The new session started on a slightly positive note as MDT opened 0.700% higher at 99.29 versus 98.60. The sector opens with a modest gain of 1.22%, offering a light tailwind for MDT. Medtronic rises amid positive analyst outlook and recent earnings beat, boosting investor confidence.

Price Change

from $98.6 close

+$1.46

Trading Volume

Below avg (7.5M)

1.9M

vs S&P 500 Today

Outperforming Market

+0.60%

52-Week Position

Upper range

76.6%

Updated: January 21, 2026 at 15:38 UTC

Quote Summary
OpenPrevious Close
$99.29$98.6
Day Range52 Week Range
$98.74 - $100.98$79.55 - $106.33
VolumeAvg. Volume
4.5M6.8M
Market CapP/E Ratio
$128B27.1